Local Bounti CorporationDE
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations for the years ended and
(in thousands, except per share data)
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Sales | $27,557 | $19,474 |
| Cost of goods sold(2)(3)(4) | 25,341 | 17,259 |
| Gross profit | 2,216 | 2,215 |
| Operating expenses: | ||
| Research and development(3)(4) | 16,086 | 14,059 |
| Selling, general and administrative(3)(4) | 64,559 | 82,682 |
| Goodwill impairment | 38,481 | — |
| Total operating expenses | 119,126 | 96,741 |
| Loss from operations | (116,910) | (94,526) |
| Other income (expense): | ||
| Change in fair value of warrant liability | 18,483 | — |
| Interest expense, net | (25,745) | (16,734) |
| Other income | 157 | 189 |
| Net loss | $(124,015) | $(111,071) |
| Net loss applicable to common stockholders per basic common share: | ||
| Basic and diluted(1) | $(15.61) | $(16.57) |
| Weighted average common shares outstanding: | ||
| Basic and diluted(1) | 7,943,874 | 6,701,126 |
(1) Prior comparative period share and per share amounts have been retroactively adjusted to reflect the June 15, 2023 Reverse Stock Split (as defined below). See Note 12, Stockholders' Equity, for additional detail.
.
(2)Amounts include the impact for non-cash increase in cost of goods sold attributable to the fair value basis adjustment to inventory in connection with the Pete's Acquisition (as defined below) as follows:
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Cost of goods sold | $— | $1,042 |
| Total business combination fair value basis adjustment to inventory | $— | $1,042 |
(3)Amounts include stock-based compensation as follows:
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Cost of goods sold | $123 | $104 |
| Research and development | 1,464 | 2,057 |
| Selling, general and administrative | 14,687 | 37,005 |
| Total stock-based compensation expense, net of amounts capitalized | $16,274 | $39,166 |
(4)Amounts include depreciation and amortization as follows:
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Cost of goods sold | $3,513 | $2,957 |
| Research and development | 2,505 | 1,304 |
| Selling, general and administrative | 7,114 | 6,166 |
| Total depreciation and amortization | $13,132 | $10,427 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.